Daniel E. Ewoldsen - 01 Jul 2021 Form 4 Insider Report for GENESCO INC (GCO)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
06 Jul 2021, 16:24:08 UTC
Prior SEC filing
30 Jun 2021
Next SEC filing
24 Sep 2021
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Daniel E. Ewoldsen

Key filing fact

Daniel E. Ewoldsen filed Form 4 for GENESCO INC (GCO) on 06 Jul 2021.

Key facts

  • This page summarizes Daniel E. Ewoldsen's Form 4 filing for GENESCO INC (GCO).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 06 Jul 2021, 16:24.

Change

  • Previous filing in this sequence was filed on 30 Jun 2021.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GCO transaction

Common Stock

Award

Transaction value
$0
Shares
+5,964
Change %
+24%
Price
$0.000000
Shares after
30,858
Date
01 Jul 2021
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Grant of restricted stock under 2020 Equity Incentive Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .